Della Bruna R, Bernhard I, Gess B, Schricker K, Kurtz A
Institut für Physiologie, Universität Regensburg, Germany.
Pflugers Arch. 1995 Jun;430(2):265-72. doi: 10.1007/BF00374658.
This study aimed to investigate the inter-relation between the angiotensin II (ANG II) AT1 receptor and renin gene expression in rat kidneys. To this end, renin mRNA levels and mRNA levels for AT1a and AT1b were assayed by RNase protection in the kidneys of normal rats, in animals treated with the AT1 antagonist losartan and in rats bearing 0.2-mm left renal artery clips for 2 days. In normal rats, we found a negative correlation between renin mRNA levels and AT1a receptor mRNA levels. Losartan led to a fourfold increase in renin mRNA levels without changing AT1 receptor mRNA levels. Unilateral renal artery clipping increased renin mRNA levels fourfold in the clipped kidney and suppressed renin mRNA levels in the contralateral kidneys. AT1 receptor mRNA levels were not changed in the contralateral intact kidneys, but were significantly decreased by 15-25% in the clipped kidneys. Renin mRNA levels were inversely correlated to AT1a mRNA levels in the clipped, but not in the contralateral, kidneys. Our findings suggest that the systemic activity of the renin angiotensin system has no regulatory influence on renal AT1 receptor gene expression. Renin mRNA levels in normal and in clipped kidneys appear to be negatively determined by the level of AT1a receptor gene expression. Thus modulation of AT1a receptor gene expression could be a pathway for indirect modulation of renin gene expression by ANG II. This conclusion is in agreement with the observation that AT1 receptor antagonists are powerful stimulators of the renin system.
本研究旨在探讨大鼠肾脏中血管紧张素II(ANG II)AT1受体与肾素基因表达之间的相互关系。为此,通过核糖核酸酶保护法检测了正常大鼠、用AT1拮抗剂氯沙坦治疗的动物以及左肾动脉夹闭0.2毫米2天的大鼠肾脏中肾素mRNA水平以及AT1a和AT1b的mRNA水平。在正常大鼠中,我们发现肾素mRNA水平与AT1a受体mRNA水平呈负相关。氯沙坦使肾素mRNA水平增加了四倍,而AT1受体mRNA水平未改变。单侧肾动脉夹闭使夹闭侧肾脏的肾素mRNA水平增加了四倍,并抑制了对侧肾脏的肾素mRNA水平。对侧完整肾脏的AT1受体mRNA水平未改变,但夹闭侧肾脏的AT1受体mRNA水平显著降低了15% - 25%。在夹闭侧肾脏中,肾素mRNA水平与AT1a mRNA水平呈负相关,而在对侧肾脏中并非如此。我们的研究结果表明,肾素 - 血管紧张素系统的全身活性对肾脏AT1受体基因表达没有调节作用。正常和夹闭肾脏中的肾素mRNA水平似乎由AT1a受体基因表达水平负向决定。因此,调节AT1a受体基因表达可能是ANG II间接调节肾素基因表达的一条途径。这一结论与AT1受体拮抗剂是肾素系统强大刺激剂的观察结果一致。